DarioHealth Corp. DRIO
6.63
(0.14)
(2.07%)
as of 25 Sep
- Market cap
- $66.3M
- P/E
- 0.0×
Follow DRIO
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (76.05%) | (82.18%) | (88.23%) | (95.54%) |
+8 more TTM periods Free account |
|
| (44.19%) | (51.09%) | (53.93%) | (55.99%) | ||
ROIC |
(27.67%) | (29.57%) | (31.63%) | (33.85%) | |
Return on Tangible Assets |
(346.95%) | (281.16%) | (234.80%) | (190.37%) | |
Average Days of Receivables |
72.19 | 74.03 | 73.54 | 76.55 | |
Free Cash Flow per Share |
(2.73) | (3.86) | (6.55) | (8.58) | |
Free Cash Flow |
(25.47) | (25.43) | (26.08) | (26.92) | |
Capital Expenditures |
(0.13) | (0.14) | (0.14) | (0.14) | |
Piotroski F-Score |
3.00 | 3.00 | 3.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(25.24%) | (22.27%) | (20.77%) | (19.46%) | |
Accounts Receivable Turnover |
4.40 | 4.16 | 3.84 | 3.65 | |
Accounts Payable Turnover |
2.68 | 2.96 | 3.25 | 3.48 | |
Inventory Turnover |
2.11 | 2.09 | 2.14 | 2.22 | |
Average Days of Payables |
131.79 | 137.47 | 110.25 | 118.68 | |
Days of Inventory on Hand |
154.46 | 165.38 | 162.51 | 166.57 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.00 | |
Research and Development Expense of Revenue |
49.75% | 56.95% | 61.68% | 66.46% | |
Selling, General and Administrative Expense of Revenue |
160.00% | 162.66% | 158.90% | 151.16% | |
Share Based Compensation of Revenue |
33.63% | 39.94% | 41.88% | 40.10% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.56 | 0.45 | 0.42 | 0.42 | |
Depreciation/Fixed assets |
4.21 | 4.71 | 5.72 | 7.60 | |
Capex/Depreciation |
(0.06) | (0.06) | (0.05) | (0.03) | |
Revenue per Share |
2.25 | 3.22 | 5.61 | 7.88 | |
Operating CF per Share |
(2.71) | (3.84) | (6.51) | (8.54) | |
Capex per Share |
(0.01) | (0.02) | (0.04) | (0.04) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(215.63%) | (263.88%) | (276.11%) | (257.74%) |
Columns are period end dates